In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
1855 News Items found
See Dr. Deb Schrag standing in a hallway. She led a clinical trial involving rectal cancer at Memorial Sloan Kettering.
Rectal Cancer Treatment Without Radiation: A New Option

Learn about a clinical trial at Memorial Sloan Kettering that gives people with rectal cancer a new option to be treated without radiation. The research shows that a well-known chemotherapy regimen used alone can be just as effective as chemotherapy given with radiation before surgery. The new method may reduce side effects associated with radiation such as loss of fertility and impaired bladder and sexual function.
Dr. Piro Lito
In the Lab
Potential Drug Shows Promise Targeting a Range of KRAS-Driven Cancers in the Lab

MSK investigators report exciting results for a new molecule that can block 16 different mutated forms of the KRAS protein. In the lab, the compound was effective against many cancer cell lines and in mouse models of lung cancer and colorectal cancer.
Back row from left to right: Zongmin Wang, Miguel Miranda-Román, Stella Paffenholz, Anton Dobrin, Bradley Benjamin, Caroline Gleason, Paige Arnold, and Mollie Chipman. Front row, from left to right: Yasemin Kaygusuz, Maria Sirenko, Buren Li, Tingxu Chen, Nayan Jain, Florisela Herrejon Chavez, and Adele Whaley.
Feature
MSK’s 2023 Commencement Celebrates Largest Class in History and Honors Award Winners

MSK's 44th annual Academic Convocation and Commencement celebrated the Gerstner Sloan Kettering Graduate School of Biomedical Sciences class of 2023, honored students graduating from the Sloan Kettering Division of the Weill Cornell Medicine Graduate School of Medical Sciences, and recognized winners of several awards and fellowships.
a composite showing a black and white, historical photo of a woman at the microscope on the left, and a modern version of a similar picture on the right
MSK’s Sloan Kettering Institute Celebrates 75 Years of Discovery

Over the last seven and a half decades, researchers at the Sloan Kettering Institute have made important contributions to the fundamental understanding of human biology, as well as driven practice-changing innovations in the treatment of cancer.
An MSK scientist pipettes in the lab
MSK Research Highlights, May 18, 2023

New MSK research shows how high-risk neuroblastoma evolves to be so deadly; finds continued safety and efficacy for sotorasib in patients with KRAS G12C-mutated advanced non-small cell lung cancer; and demonstrates promise in eradicating tumors by delivering a viral-based immunotherapeutic to melanoma and breast cancer in mouse models.
Dr. Grady Nelson interviews a student scientist at the science fair.
MSK Supports STEM Education at Yankee Stadium Science Fair

Three MSK researchers served as guest judges at the event, which celebrated students’ academic achievements.
Dr. Michael Overholtzer
Feature
17 Gerstner Sloan Kettering Students Will Graduate in 2023

Seventeen scientists are poised to receive their PhD degrees from the Gerstner Sloan Kettering Graduate School of Biomedical Sciences. Their years of dedication and training will be recognized on May 17, 2023, as part of Memorial Sloan Kettering’s 44th annual academic convocation.
Dana Pe'er and Scott Lowe
Expansion of Cell-to-Cell Communication Drives the Early Development of Pancreatic Cancer, New Research in Mice Finds

New MSK research combined sophisticated genetically engineered mouse models and advanced computational methods to map the earliest cell states leading to pancreatic ductal adenocarcinoma (PDAC), the most common type of pancreatic cancer.
MSK patient Michael Szczerbienski
In the Clinic
New Combination Drug Treatment Helps Some People With Stage 4 Kidney Cancer

An international phase 3 clinical trial has shown that adding a targeted therapy to a standard combination for stage 4 kidney cancer is more effective than giving the standard treatment alone, although the new combination has significant side effects.
A microscope image of a mouse embryo
The Right Moves: How Studying Cell Movement During Embryonic Development May Offer New Insights Into Cancer Metastasis

New insights into the way cells break away from a tissue during embryonic development may also shed new light on the same process in the context of cancer metastasis.